Reference
Ajlan A, et al. Optimizing bevacizumab dosing in glioblastoma: less is more. Journal of Neuro-Oncology 135: 99-105, No. 1, Oct 2017. Available from: URL: http://doi.org/10.1007/s11060-017-2553-2 - USA
Rights and permissions
About this article
Cite this article
Bevacizumab. Reactions Weekly 1679, 37 (2017). https://doi.org/10.1007/s40278-017-38762-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-38762-7